Genetically-informed prediction of short-term Parkinson's disease progression.
Ontology highlight
ABSTRACT: Parkinson's disease (PD) treatments modify disease symptoms but have not been shown to slow progression, characterized by gradual and varied motor and non-motor changes overtime. Variation in PD progression hampers clinical research, resulting in long and expensive clinical trials prone to failure. Development of models for short-term PD progression prediction could be useful for shortening the time required to detect disease-modifying drug effects in clinical studies. PD progressors were defined by an increase in MDS-UPDRS scores at 12-, 24-, and 36-months post-baseline. Using only baseline features, PD progression was separately predicted across all timepoints and MDS-UPDRS subparts in independent, optimized, XGBoost models. These predictions plus baseline features were combined into a m
SUBMITTER: Sadaei HJ
PROVIDER: S-EPMC9613892 | biostudies-literature | 2022 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA